Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Cash Flow Quality Index
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow Quality Index of 2.18x as of September 2025. Operating cash flow of CN¥1.73 Billion exceeds net income of CN¥793.91 Million, indicating high earnings quality where cash backs reported profits. Explore Guangzhou Baiyunshan Pharmaceutical Hold cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Quality Index (2000–2025)
Historical Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Guangzhou Baiyunshan Pharmaceutical Hold to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year earnings quality comparison for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For live market cap and the full company financial profile, see 600332 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥260.23 Million | CN¥2.98 Billion | ▼ -92.4% |
| 2024 | 1.15x | CN¥3.44 Billion | CN¥3.00 Billion | ▲ +19.1% |
| 2023 | 0.96x | CN¥4.10 Billion | CN¥4.26 Billion | ▼ -41.5% |
| 2022 | 1.65x | CN¥7.00 Billion | CN¥4.25 Billion | ▲ +15.1% |
| 2021 | 1.43x | CN¥5.67 Billion | CN¥3.97 Billion | ▲ +655.2% |
| 2020 | 0.19x | CN¥585.19 Million | CN¥3.09 Billion | ▼ -87.0% |
| 2019 | 1.46x | CN¥5.02 Billion | CN¥3.44 Billion | ▼ -1.1% |
| 2018 | 1.48x | CN¥5.22 Billion | CN¥3.53 Billion | ▲ +70.6% |
| 2017 | 0.87x | CN¥1.83 Billion | CN¥2.12 Billion | ▼ -44.8% |
| 2016 | 1.57x | CN¥2.44 Billion | CN¥1.56 Billion | ▲ +8.7% |
| 2015 | 1.44x | CN¥1.94 Billion | CN¥1.35 Billion | ▼ -0.8% |
| 2014 | 1.45x | CN¥1.76 Billion | CN¥1.21 Billion | ▲ +9.4% |
| 2013 | 1.33x | CN¥1.34 Billion | CN¥1.01 Billion | ▲ +7.2% |
| 2012 | 1.24x | CN¥506.53 Million | CN¥408.33 Million | ▲ +306.7% |
| 2011 | -0.60x | CN¥-180.05 Million | CN¥300.00 Million | ▼ -324.8% |
| 2010 | 0.27x | CN¥73.17 Million | CN¥274.03 Million | ▼ -87.3% |
| 2009 | 2.10x | CN¥439.39 Million | CN¥208.77 Million | ▲ +5830.0% |
| 2008 | 0.04x | CN¥6.10 Million | CN¥171.96 Million | ▼ -96.7% |
| 2007 | 1.09x | CN¥375.74 Million | CN¥344.66 Million | ▲ +571.7% |
| 2006 | 0.16x | CN¥38.88 Million | CN¥239.54 Million | ▼ -78.5% |
| 2005 | 0.75x | CN¥146.32 Million | CN¥194.13 Million | ▼ -75.9% |
| 2004 | 3.13x | CN¥200.54 Million | CN¥64.07 Million | ▲ +6989.5% |
| 2003 | -0.05x | CN¥-6.83 Million | CN¥150.35 Million | ▼ -104.7% |
| 2002 | 0.97x | CN¥169.01 Million | CN¥174.38 Million | ▲ +8.5% |
| 2001 | 0.89x | CN¥140.15 Million | CN¥156.93 Million | ▼ -54.5% |
| 2000 | 1.96x | CN¥286.95 Million | CN¥146.23 Million | — |